Recent studies show solid association between mRNA and serum IGFBP2 and metabolic disorders, including obesity, metabolic syndrome, insulin resistance, and type 2 diabetes, as detailed below. Here, IGFBP2 is linked to obesity due to melanocortin 4 receptor deficiency.